Auster Martin's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Jun 7, 2023
- Accession no.
- 0001209191-23-035224
- Filed
- Jun 7, 2023
- Trade date
- Jun 6, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $969.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Auster MartinCIK 0001875786 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | Common Stock | MOption exerciseAcquired | +28,000 | $3.45 | +$96,600 | 75,649 | Direct | |
| Jun 6, 2023 | Common Stock | SSaleDisposed | −24,246 | $34.59F2 | −$838,669.14 | 51,403 | Direct | |
| Jun 6, 2023 | Common Stock | SSaleDisposed | −3,754 | $34.95F3 | −$131,202.3 | 47,649 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | Common Stock | MOption exerciseDisposed | −28,000 | $0.00 | $0 | 247,184 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 24,246 shares sold in the price range of $33.90 to $34.8977. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 3,754 shares sold in the price range of $34.9041 to $35.0078. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.